Review-State-Aware Comparison
Amazonian Guaraná vs Black Caraway Seed
An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.
This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.
Amazonian Guaraná
Human-reviewed public score: 10/10
Black Caraway Seed
Human-reviewed public score: 10/10Human-Reviewed Benefit Text
Amazonian Guaraná
Black Caraway Seed
Human-Reviewed Mechanism Text
Guaraná's primary bioactive methylxanthines—caffeine (2–5% dry weight), theobromine, and theophylline—competitively antagonize adenosine A1 and A2A receptors in the central nervous system, thereby blocking adenosine's inhibitory signaling, increasing synaptic dopamine and norepinephrine release, and enhancing alertness, reaction time, and sustained attention. Its proanthocyanidins, catechins, and epicatechins scavenge reactive oxygen species (ROS) through electron donation from multiple hydroxyl groups and simultaneously activate the Keap1-Nrf2-ARE signaling axis, promoting transcription of phase II antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme oxygenase-1 (HO-1). Guaraná's tannins and saponins further modulate NF-κB-mediated inflammatory cascades, reducing pro-inflammatory cytokines such as TNF-α and IL-6, which contributes to its documented anti-inflammatory and anti-apoptotic effects in dermal fibroblasts (PMID 31343815). Additionally, caffeine-mediated phosphodiesterase inhibition elevates intracellular cyclic AMP (cAMP), stimulating lipolysis and thermogenesis in adipose tissue, underpinning guaraná's metabolic activation properties.
Thymoquinone, the principal bioactive constituent (30–48% of Nigella sativa essential oil), exerts anti-inflammatory effects primarily by inhibiting the NF-κB signaling cascade, thereby downregulating transcription of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, as well as suppressing cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and matrix metalloproteinases (MMPs) (PMID 34073784; PMID 39769174). Its antioxidant mechanism involves direct scavenging of superoxide anions and hydroxyl radicals, upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), and preservation of intracellular glutathione (GSH) levels through Nrf2 pathway activation (PMID 39807848). Thymoquinone also modulates the PI3K/Akt/mTOR and MAPK/ERK pathways, contributing to its antiproliferative and pro-apoptotic effects in cancer cell lines, while simultaneously activating AMPK signaling to improve insulin sensitivity and hepatic glucose metabolism (PMID 34073784; PMID 24111621). Additional bioactive components—thymohydroquinone, thymol, carvacrol, and α-hederin—contribute synergistically to antimicrobial activity by disrupting bacterial cell membrane integrity (PMID 23646296).
Human-Reviewed Safety Text
A comprehensive safety review by Patrick et al. (2019, PMID 31539257) confirmed that guaraná seed is generally recognized as safe (GRAS) when consumed at standard dietary doses (typically 75–200 mg/day caffeine equivalent), with adverse effects primarily dose-dependent and consistent with excess caffeine intake—including insomnia, tachycardia, anxiety, and gastrointestinal distress. Guaraná's caffeine is a substrate and inhibitor of cytochrome P450 1A2 (CYP1A2), and concurrent use with CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin) or substrates (e.g., theophylline, clozapine) may increase plasma caffeine levels and potentiate adverse effects. Guaraná should be used cautiously alongside anticoagulants (warfarin), MAO inhibitors, stimulant medications, and ephedra-containing products due to additive cardiovascular stimulation; it is contraindicated in individuals with uncontrolled hypertension, cardiac arrhythmias, or caffeine hypersensitivity. Pregnant and lactating women are advised to limit guaraná consumption consistent with general caffeine guidelines (≤200 mg caffeine/day per WHO recommendations).
Nigella sativa is generally recognized as safe at culinary doses (1–3 g seed/day) and supplemental doses up to 2–3 g/day or 200–600 mg thymoquinone-standardized oil for up to 12 weeks in clinical trials, though higher doses have been associated with gastrointestinal discomfort, nausea, and contact dermatitis in sensitive individuals (PMID 30000936; PMID 34073784). Thymoquinone has demonstrated inhibition of CYP3A4 and CYP2D6 in preclinical models, raising the potential for interactions with substrates of these enzymes including cyclosporine, warfarin, and certain antihypertensive and antidiabetic medications—concurrent use may potentiate hypoglycemic or hypotensive effects (PMID 39769174; PMID 30000936). Pregnant and breastfeeding women should avoid therapeutic doses, as uterotonic effects have been observed in animal studies; individuals scheduled for surgery should discontinue use at least two weeks prior due to potential antiplatelet activity (PMID 34073784). Hepatotoxicity has been reported in rare cases at very high doses, and liver function should be monitored during prolonged high-dose supplementation (PMID 30000936).
Comparison summary
This automated view does not establish that either Amazonian Guaraná or Black Caraway Seed is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.
Frequently Asked Questions
Is Amazonian Guaraná or Black Caraway Seed better?
Amazonian Guaraná and Black Caraway Seed have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.
Can you take Amazonian Guaraná and Black Caraway Seed together?
No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.
What is the main difference between Amazonian Guaraná and Black Caraway Seed?
Amazonian Guaraná is categorized as seed (Compound), while Black Caraway Seed is categorized as seed (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.